News
Zacks Investment Research on MSN18h
MRK Pins Hopes on New PAH Drug Winrevair Amid Looming Keytruda LOEMerck’s MRK blockbuster PD-L1 inhibitor, Keytruda, approved for several types of cancer indications, is the company's biggest ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback